CBM2

Cancer Research Delayed Due to Pandemic Shutdown

While research on the disease caused by the novel coronavirus has been on a fast track the past several months, most other medical research ground to a halt in March and has yet to resume at anything near its pre-COVID pace. It is impossible to know the full implications of suspended work, lost experiments and delayed clinical trials, but for those waiting for a cure, time matters.

For more information, download the fact sheets: "AN UNPRECEDENTED IMPACT: A Series of Fact Sheets on COVID-19 and Biomedical Research".